Navigation Links
RxTrials Announces Hiring Adam Chasse as VP of Business Development
Date:5/11/2011

ELLICOTT CITY, Md., May 11, 2011 /PRNewswire/ -- Christine Pierre, president of RxTrials, Inc., today named Adam Chasse vice president of business development. Chasse, who has been head of prime sites for Quintiles, will begin on May 11 and be based in Triangle Park, North Carolina.

"I have collaborated with Adam for 16 years and have admired what he has accomplished personally and for his employer, but what really stands out for me is his integrity. Yes, he brings a global perspective and valuable experience gained by working for the largest contract research organization in the world, but, more importantly, he brings a vision for the future of our organization that is closely aligned with that of our other top managers," said Pierre.

Chasse has served on the board of advisors for the Site Solutions Summit since its inception seven years ago. The Summit is an annual industry meeting organized by RxTrials Institute and focused on research sites' best practices. RxTrials Institute is an RxTrials affiliate.

"Quite frankly he was my first choice; I've been asking him for about five years when he was going to come to the other side and join the sites world," said Pierre with a smile.

"I'm very, very excited because I've always admired RxTrials for its history of delivery and quality, and its forward-thinking approach to improving research practices," said Chasse.

Chasse and Pierre agree that it is becoming increasingly difficult for independent research practices to leverage the economies of scale necessary to be successful. A network of research sites, they say, provides ways to keep sites busier and guarantee high-quality end results while assuring positive patient experiences.

RxTrials has eight research sites located in five states, all of which are located within clinical practices or hospitals.  "Adam will provide RxTrials with strategic site development and study placement opportunities focused on our clients' needs," said Pierre.

"RxTrials' vision for expanding opportunities for patients and physicians to take part in important research is identical to mine, so I feel we're a perfect fit," said Chasse.

"It's so expensive to take a drug through the research process, which has been further complicated by the fact that pharma companies are looking at rarer diseases than they were 10 years ago. Therefore, it's more difficult to run a trial in the same period of time partly because it's harder to find enough patients," said Chasse. "On top of that, study designs are getting more complex and investigators are being challenged to recruit more patients while adding procedures and tests. Plus, there is more scrutiny of data by Sponsors and FDA."

"What Sponsors and physicians need is an entity that can help them navigate that process," added Pierre.

"Christine is an innovator and recognized leader in the industry. She has the respect of everyone who knows her. Hers is one of the very few site networks that emerged since 1990 that is still not only around but thriving," said Chasse.

"The deal was recently closed and not yet publically announced and I've already fielded calls from colleagues in the industry. It seems good news travels fast," said Pierre.

About RxTrials, Inc.

RxTrials is a network of premier Investigative Sites based in physician practices and hospitals that conduct Phase II through Phase IV and vaccine clinical research studies. Since 1994, RxTrials has successfully completed more than 1,000 studies and is a strategic partner with leading Sponsors and CROs.  Its affiliate, RxTrials Institute, provides professional training, education and consultation, and sponsors the annual Site Solutions Summit.

Interviews and print-quality images of the logo and personnel are available upon request.


'/>"/>
SOURCE RxTrials, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. RxTrials Earns National Women-Owned Business Certification
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. Anesiva Announces Second Quarter 2008 Financial Results and Update
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
8. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. ThirdBiotech Announces Kemeta as Newest Sponsor
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... A new study published in ... and fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched ... , After comparing the results from the fresh and frozen transfer cohorts, the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
(Date:10/10/2017)... research firm Parks Associates announced today that Tom Kerber ... Annual Meeting , October 11 in Scottsdale, Arizona . ... how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the ...
Breaking Biology Technology:
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
(Date:4/18/2017)...  Socionext Inc., a global expert in SoC-based imaging and computing ... M820, which features the company,s hybrid codec technology. A demonstration utilizing ... Inc., will be showcased during the upcoming Medtec Japan at Tokyo ... Las Vegas Convention Center April 24-27. ... Click here for an image ...
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
Breaking Biology News(10 mins):